Although the role of the activation of the miR-132/SIRT1/TP53 pathway in CLL remains obscure, it may represent part of a normal negative feedback mechanism to limit B cell expansion or eliminate autoreactive B cells. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.